Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the U.S. District Court for the District of Delaware.
On May 24, 2022, the Consumer Financial Protection Bureau (CFPB) announced that it is replacing the Office of Innovation with the newly-established Office of Competition and Innovation.
On April 21, 2022, Assistant Attorney General Jonathan Kanter gave a spirited keynote address at the University of Chicago, declaring "that the era of lax enforcement is over, and the new era of vigorous.
Enforcement by private competition litigation in Austria is not restricted to damages claims. Private bodies have standing to file for cease and desist (Abstellung) orders or for decisions of finding.
When the Federal Trade Commission ("FTC") or Department of Justice ("DOJ") believes a merger or acquisition will have anti-competitive effects, it typically either attempts to.